[ Price : $8.95]
An FDA advisory committee reviews a Bayer-proposed risk management plan for Trasylol intended to reduce hypersensitivity reactions...[ Price : $8.95]
FDA clears a PreMD Inc. 510(k) for a new color reader for its Prevu(x) Point of Care Skin Sterol Test used to assess risk of heart...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for patent extension for American Cyanamids Cydectin.[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Pharmacia & Upjohns Aptivus for patent extension.[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Fuzeon is 2,312 days for patent extension.[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Genentechs Avastin for patent extension.[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Gilead Sciences Macugen for patent extension.[ Price : $8.95]
FDA says labeling for Ortho Evra has been updated with results from two studies on the risk of blood clots.